Namibia to launch program that will address HIV/AIDS among workers at sea

NewsGuard 100/100 Score

A program that will provide employees in Namibia who work at sea with information on HIV/AIDS and focus on antiretroviral treatment is in an advanced stage of development, the New Era/AllAfrica.com reports.

According to the New Era/AllAfrica.com, the program is needed to address this group's vulnerability to HIV/AIDS because of a lack of information and to ensure that HIV-positive employees do not miss scheduled doses of antiretrovirals. Representatives from the Ministry of Health and Social Services, fishing companies and other HIV/AIDS service providers met last week to create a committee that will oversee the program's implementation.

According to assessments, the extended period of absence at sea can disrupt the antiretroviral regimens of employees living with HIV/AIDS because they often are unable to take the drugs at sea. Although the health ministry does make arrangements for HIV-positive employees to receive treatment, most employees are unaware of such arrangements, the New Era/AllAfrica.com reports.

Immanuel Mwilima of the Walvis Bay Multi-Purpose Centre Trust, which will lead the program, said the initiative could be effective in addressing the vulnerability of sea-going employees to HIV/AIDS. "Such a program will cater for the very basic needs in form of information and education for seafarers when it comes to HIV/AIDS," Mwilima said, adding, "These people are very vulnerable, as most information does not reach them due to their extended length of stay at sea."

Mwilima added that Namibia will pilot the program and that if successful, it could be rolled out to other countries. "We have very high expectations for this program and will do everything possible to make sure that it succeeds. If successful, Namibia could be used as a model for other countries facing the same scenario worldwide," Mwilima said (Tjatindi, New Era/AllAfrica.com, 8/21).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New report on HIV drug resistance: Challenges and recommendations